+41 91 682 20 40
info@elixi-int.com
Reserved Area
Login
Register
Request Document
Send Document
Home
About Us
Services
Quality
News
Case Studies
Contact
Let's talk
info@yourwebsite.com
+1 (555) 123-4567
Search
unresectable locally advanced or metastatic triple-negative breast cancer (mTNBC).
25 October 2021
Trodelvy (sacituzumab govitecan), First-in-class medicine to treat aggressive form of breast cancer
by Elixi